HIV-1 superinfection

Current Opinion in Infectious Diseases

Volumn 25, Issue 1, 2012, Pages 42-50

  Waters, Laura ^a   Smit, Erasmus ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Dual infection; HIV 1; Superinfection

Indexed keywords

CD4 LYMPHOCYTE COUNT; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYBRIDIZATION; IMMUNE RESPONSE; INFECTION RISK; LIMIT OF DETECTION; MIXED INFECTION; NONHUMAN; PATHOGEN CLEARANCE; PATIENT COUNSELING; PHYLOGENY; PRACTICE GUIDELINE; REINFECTION; REVIEW; SECONDARY INFECTION; SEROCONVERSION; SUPERINFECTION; UNSAFE SEX; VIRUS DETECTION; VIRUS LOAD; VIRUS STRAIN;

COUNSELING; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; PRACTICE GUIDELINES AS TOPIC; SPECIES SPECIFICITY; SUPERINFECTION;

EID: 84155166958     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32834ef5af     Document Type: Review

References (61)

1. Rak Nandwani on behalf of the Clinical Effectiveness Group of the British Association for Sexual Health and HIV. 2005 United Kingdom national guideline on the sexual health of people with HIV: sexually transmitted infections. Int J STD AIDS 2006; 17:594-606.
2. Fakoya A, Lamba H, Mackie N, et al. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Med 2008; 9:681-720.
3. British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. http://www.bhiva.org/ documents/Guidelines/Monitoring/4-BHIVA-Monitoring-Guidelines-with-hdr.pdf. [Accessed 1 November 2011]
4. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
5. Cohen M. HIV treatment as prevention and 'the Swiss Statement': in for a dime, in for a dollar? Clin Infect Dis 2010; 51:1323-1324.
6. McFarland W, Chen YH, Raymond HF, et al. HIV seroadaptation among individuals, within sexual dyads, and by sexual episodes, men who have sex with men, San Francisco, 2008. AIDS Care 2011; 23:261-268.
7. Blick G, Kagan RM, Coakley E, et al. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J Infect Dis 2007; 195:1250-1259.
8. Van der Kuyl AC, Cornelissen M. Identifying HIV-1 dual infections. Retrovirology 2007; 4:67.
9. Chang CM, Yu KJ, Mbulaiteye SM, et al. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal. Virus Res 2009; 143:209-221.
10. Hansen SG, Powers CJ, Richards R, et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010; 328:102-106.
11. van der Kuyl AC, Kozaczynska K, Van den Burg R, et al. Triple HIV-1 infection. N Engl J Med 2005; 352:2557-2559.
12. Rachinger A, Manyenga P, Burger JA, et al. Low incidence of HIV-1 superinfection even after episodes of unsafe sexual behavior of homosexual men in the Amsterdam Cohort Studies on HIV Infection and AIDS. J Infect Dis 2011;203:1621-1628.
13. Rachinger A, van de Ven TD, Burger JA, et al. Evaluation of prescreening methods for the identification of HIV-1 superinfection. J Virol Methods 2010; 165:311-317.
14. Piantadosi A, Ngayo MO, Chohan B, Overbaugh J. Examination of a second region of the HIV type 1 genome reveals additional cases of superinfection. AIDS Res Hum Retroviruses 2008; 24:1221-1224.
15. Piantadosi A, Chohan B, Chohan V, et al. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 2007; 3:e177.
16. Templeton AR, Kramer MG, Jarvis J, et al. Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women. Retrovirology 2009; 6:54.
17. CornelissenM, Jurriaans S, Kozaczynska K, et al. Routine HIV-1 genotyping as a tool to identify dual infections. AIDS 2007; 21:807-811.
18. Koelsch KK, Smith DM, Little SJ, et al. Clade B HIV-1 superinfection with wildtype virus after primary infection with drug-resistant clade B virus. AIDS 2003; 17:F11-F16.
19. Smith DM, Wong JK, Hightower GK, et al. HIV drug resistance acquired through superinfection. AIDS 2005; 19:1251-1256.
20. Yang OO, Daar ES, Jamieson BD, et al. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J Virol 2005; 79:860-868.
21. van der Kuyl A, Kozaczynska K, Ariën KK, et al. Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness. Retrovirology 2010; 7:60.
22. Smith DM, Wong JK, Hightower GK, et al. Incidence of HIV superinfection following primary infection. JAMA 2004; 292:1177-1178.
23. Jost S, Bernard MC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med 2002; 347:731-736.
24. Pernas M, Casado C, Fuentes R, et al. A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006; 42:12-18.
25. Smith DM, Strain MC, Frost SD, et al. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology 2006; 355:1-5.
26. Jurriaans S, Kozaczynska K, Zorgdrager F, et al. A sudden rise in viral load is infrequently associated with HIV-1 superinfection. J AIDS 2008; 47:69-73.
27. Doyle T, Garcia-Diaz AM, Ambrose J, et al. Detecting HIV-1 superinfection by pol population sequencing among untreated HIV-1-infected men who experience sudden rises in plasma HIV-1 RNA load. AIDS 2011; 25:542-544.
28. Pacold M, Smith D, Little S, et al. Comparison of methods to detect HIV dual infection. AIDS Res Hum Retroviruses 2010; 26:1291-1298.
29. Redd AD, Collinson-Streng A, Martens C, et al. Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing. J Clin Microbiol 2011; 49:2859-2867.
30. Rowland-Jones SL, Dong T, Fowke KR, et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998; 102:1758-1765.
31. Kaul R, Trabattoni D, Bwayo JJ, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999; 13:23-29.
32. Stranford SA, Skurnick J, Louria D, et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. Proc Natl Acad Sci U S A 1999; 96:1030-1035.
33. Kaul R, Rowland-Jones SL, Kimani J, et al. Late seroconversion in HIV-resistant Nairobi prostitutes despite preexisting HIV-specific CD8+ responses. J Clin Invest 2001; 107:341-349.
34. Blish CA, Dogan OC, Derby NR, et al. Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses. J Virol 2008; 82:12094-12103.
35. Hemelaar J, Gouws E,Ghys PD, Osmanov S, WHO-UNAIDS Network for HIV Isolation and Characterisation. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011; 25:679-689.
36. Gross KL, Porco TC, Grant RM. HIV-1 superinfection and viral diversity. AIDS 2004; 18:1513-1520.
37. Ssemwanga D, Lyagoba F, Ndembi N, et al. Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk rural clinical cohort in Uganda. Virology 2011; 411:113-131.
38. Morrison CS, Chen PL, Nankya I, et al. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe. J Acquir Immune Defic Syndr 2011; 57:157-164.
39. Rangsin R, Piyaraj P, Sirisanthana T, et al. The natural history of HIV-1 subtype E infection in young men in Thailand with up to 14 years of follow-up. AIDS 2007; 21(Suppl 6):S39-S46.
40. Todd J, Glynn JR, Marston M, et al. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007; 21 (Suppl 6):S55-S63.
41. Kiwanuka N, Robb M, Laeyendecker O, et al. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 2010; 54:180-184.
42. Clerc O, Colombo S, Yerly S, et al. HIV-1 elite controllers: beware of superinfections. J Clin Virol 2010; 47:376-378.
43. Fultz PN, Srinivasan A, Greene CR, et al. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J Virol 1987; 61:4026-4029.
44. Angel JB, Hu Y-W, Kravcik S, et al. Virological evaluation of the 'Ottawa case' indicates no evidence for HIV-1 superinfection. AIDS 2004; 18:331-334.
45. Ramos A, Hu DJ, Nguyen L, et al. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002; 76:7444-7452.
46. Altfeld M, Allen TM, Yu XG, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002; 420:434-439.
47. Campbell TB. Are all HIV type 1 strains created equal? Clin Infect Dis 2006; 42:853-854.
48. Chohan B, Lavreys L, Rainwater SMJ, Overbaugh J. Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J Virol 2005; 79:10701-10708.
49. Gonzales MJ, Delwart E, Rhee S-Y, et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J Infect Dis 2003; 188:397-405.
50. Manigart O, Courgnaud V, Sanou O, et al. HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure. AIDS 2004; 18:1645-1651.
51. Fang G, Weiser B, Kuiken C, et al. Recombination following superinfection by HIV-1. AIDS 2004; 18:153-159.
52. Yerly S, Jost S, Monnat M, et al. HIV-1 co/super-infection in intravenous drug users. AIDS 2004; 18:1413-1421.
53. Tsui R, Herring BL, Barbour JD, et al. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure. J Virol 2004; 78:94-103.
54. Hu DJ, Subbarao S, Vanichseni S, et al. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. AIDS 2005; 19:303-308.
55. Chakraborty B, Valer L, De Mendoza C, et al. Failure to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus. AIDS Res Hum Retroviruses 2004; 20:1026-1031.
56. Kiwanuka N, Laeyendecker O, Quinn TC, et al. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai, Uganda. AIDS 2009; 23:2479-2484.
57. Galimand J, Frange P, Rouzioux C, et al. Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France - ANRS CO06 PRIMO Cohort. AIDS Res Hum Retroviruses 2010; 26:645-651.
58. Matucci A, Rossolillo P, Baroni M, et al. HLA-C increases HIV-1 infectivity and is associated with gp120. Retrovirology 2008; 5:68.
59. Herbinger KH, Gerhardt M, Piyasirisilp S, et al. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res Hum Retroviruses 2006; 22:599-606.
60. Marcus JL, McConnell JJ, Grant RM. HIV superinfection vs dual initial infection: what clinicians and patients should know. http://www.medscape.com/ viewarticle/504811-2. [Accessed on 21 October 2011]
61. 2011 BHIVA PEP Guidelines. http://www.bhiva.org/documents/Guidelines/ PEPSE/PEPSE-final-24th-February-2011.pdf. [1 November 2011]